Concepedia

Author

Kalpana Antony

Program for Appropriate Technology in Health

Also Known As

Kalpana Antony

14

Publications

651

Citations

11

H-Index

7

Concepts

All Affiliations

Program for Appropriate Technology in HealthProgram for Appropriate Technology in HealthChristian Medical College, VelloreSociety for Applied StudiesSerum Institute of India (India)
KA

About

Kalpana Antony is an author at Program for Appropriate Technology in Health specializing in vaccination, vaccine development, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

317

2

Immunology

1

1

317

3

Vaccine Development

1

1

317

4

Vaccination

1

1

317

5

Vaccine Safety

1

1

317

Kalpana Antony

×

11

Publications

645

Citations

11

H-Index

YearCitations

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

Nita Bhandari, Temsunaro Rongsen‐Chandola, Ashish Bavdekar,

The Lancet

2014

317

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life

Nita Bhandari, Temsunaro Rongsen‐Chandola, Ashish Bavdekar,

Vaccine

2014

100

Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human–Bovine (116E) Oral Rotavirus Vaccine, Rotavac, India

Ira Praharaj, James A Platts-Mills, Sunita Taneja,

Clinical Infectious Diseases

2018

44

Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial

Ed Clarke, Adedapo Olufemi Bashorun, Ikechukwu Adigweme,

The Lancet Infectious Diseases

2021

38

ROTAVAC ® does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial

Temsunaro Rongsen Chandola, Sunita Taneja, Nidhi Goyal,

Heliyon

2017

32

Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India

Jacob John, Anand Kawade, Temsunaro Rongsen‐Chandola,

Vaccine

2014

29

Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9–14 years of age: Interim analysis from a phase 3 clinical trial

Khalequ Zaman, Anne Schuind, Samuel Adjei,

Vaccine

2024

22

Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine

Sajjad Desai, Niraj Rathi, Anand Kawade,

Vaccine

2018

21

A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Niraj Rathi, Sajjad Desai, Anand Kawade,

Vaccine

2018

18

Assessment of risk of intussusception after pilot rollout of rotavirus vaccine in the Indian public health system

Nita Bhandari, Kalpana Antony, Vinohar Balraj,

Vaccine

2020

12

Page 1